CORVUS PHARMACEUTICA

CRVS
Delayed Quote. Delayed  - 10/20 04:00:00 pm
4.73USD +1.50%

Turn to zoom
Prev.4.6600
Open4.6200
High4.7650
Low4.5200
Volume560 584
Latest news
09/22
09/22
09/22
09/22
Chart CORVUS PHARMACEUTICALS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance8,538,536,80
Spread/Res.-45%-45%-30%
Spread/Supp.15%15%33%
Support4,134,133,56
Financials
Sales 2021 - - -
Net income 2021 -40,1 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,93x
Yield 2021 -
Capitalization 201 M 201 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 5,88x
Nbr of Employees 42
Free-Float 88,4%
Company
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which is engaged in the development and commercialization of precisely targeted oncology therapies. The Company develops drugs and antibodies that target the critical cellular elements of the immune system. The Company's...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-11-04 Earnings Release
Trading Rating :
Investor Rating : -

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 4,73 $
Average target price 5,13 $
Spread / Average Target 8,35%